Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

Vandana Mehta, C. Balachandran

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

Original languageEnglish
Pages (from-to)140-141
Number of pages2
JournalIndian Journal of Dermatology
Volume53
Issue number3
Publication statusPublished - 01-07-2008
Externally publishedYes

Fingerprint

imiquimod
Basal Cell Carcinoma
Skin
Neoplasms

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Mehta, Vandana ; Balachandran, C. / Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream. In: Indian Journal of Dermatology. 2008 ; Vol. 53, No. 3. pp. 140-141.
@article{e19e7b868a4941b497a9a021895062a0,
title = "Pigmented basal cell carcinoma successfully treated with 5{\%} imiquimod cream",
abstract = "Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80{\%} of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100{\%}. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5{\%} cream.",
author = "Vandana Mehta and C. Balachandran",
year = "2008",
month = "7",
day = "1",
language = "English",
volume = "53",
pages = "140--141",
journal = "Indian Journal of Dermatology",
issn = "0019-5154",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream. / Mehta, Vandana; Balachandran, C.

In: Indian Journal of Dermatology, Vol. 53, No. 3, 01.07.2008, p. 140-141.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

AU - Mehta, Vandana

AU - Balachandran, C.

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

AB - Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

UR - http://www.scopus.com/inward/record.url?scp=53849141832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849141832&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:53849141832

VL - 53

SP - 140

EP - 141

JO - Indian Journal of Dermatology

JF - Indian Journal of Dermatology

SN - 0019-5154

IS - 3

ER -